Venture funds omit diagnostics companies: Few success stories

Scoring a success with diagnostics products is hard - so hard that several venture funds refrain from investing in such projects. Danish Novo Seeds and Sunstone Capital are no exeption.

Søren Møller, Managing Partner in Novo Seeds. Photo: Novo Nordisk Fonden

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles